4Mak P H.Irwin M G.The effect of cisatracurium and rocuronium on cisatracurium precurarization and the priming principle[J].J Clin Anesth,2004,16(2):83.
6Amin A M,Mohammad M Y,Ibrahim M F.Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia[J].Middle East J Anesthesiol,2009,20(1):39.
6Arain SR, Kern S, Ficke DJ, et al. Variability of duration of action of neuromuscular blocking drugs in elderly patients. Acta Anaesthesiol Scand, 2005,49 : 312-315.
7Krieg N, Mazur L, Booij LH, et al. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC4s. Acta Anesthesiology Seand, 1980, 24: 423- 425.
8Cheymol G.Effects of obesity on pharmacokinetics implications for drug therapy.Clin pharmacokinet,2000,39:215-231.
9Sinha S,Jain AK,Bhattacharya A.Effect of nutritional-status on v-ecuronium induced neuromuscular blockade.Anaesth Intensive Care,1998,26:392-395.
10Leykin Y,Pellis T,Lucca M,et al.The effects of cisatracurium on morbidly obese women.Anesth Analg,2004,99:1090-1094.
